1 / 18

Osteoporosis Diagnosis & Monitoring Methods

Learn about the most current methods and standards for diagnosing and monitoring treatment of osteoporosis in this informative module.

carpenterp
Download Presentation

Osteoporosis Diagnosis & Monitoring Methods

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. OsteoporosisPart 2 of 3: Diagnosis Ellen Davis-Hall, PhD, PA-C Professor Clare J. Kennedy, MPAS, PA-C Assistant Professor, PA Program SAHP , COM UNMC Omaha, NE. office: 402-559-4738 email: clarekennedy@unmc.edu

  2. PROCESS Series of modules and questions Step #1: Power point module with voice overlay Step #2: Case-based question and answer Step # 3: Proceed to additional modules or take a break

  3. Objectives • Part 1: Identify risk factors for osteoporosis with an emphasis on modifiable risk factors. • Part 2: Describe the most current methods of, and standards for, diagnosis and monitoring of treatment • Part 3: Describe the available treatment modalities for osteoporosis and their effectiveness

  4. Assessment and Screening • Paper/Pencil tests • National Osteoporosis Foundation-NOF self assessment checklist • Osteoporosis Risk Assessment Instrument (ORAI) based on age, weight and estrogen use (Cadarette et al, 2000) • Simple Calculated Osteoporosis Risk Estimation (SCORE)-based on age, race, weight, estrogen use, rheumatoid arthritis and fracture history (Lydick et al, 1998) • Nomogram • Osteoporosis Self-Assessment Tool (OST)-based on age and weight on an easy to read chart (Cadarette et al, 2004)

  5. U.S Preventive Services Task Force Screening Recommendations • USPSTF • All women over 65 • Women 60-64 if “at risk” “At Risk”: • Best predictor = low body weight • Others: early menopause, white/Asian, sedentary, smoker, alcohol abuse, caffeine use, low calcium and vitamin D intake, family history, primary hyperparathyroid, hyperthytroid, corticosteroids, phenytoin Cadarette SM, Jaglal SB, Murray T, et al. Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA 2001;286(1):57-63.

  6. National Osteoporosis Foundation • Screen if these risk factors are present: • All women 65 and older • Postmenopausal women under age 65 with: • Family history of osteoporosis • Past history of low trauma fracture if over 45 • Cigarette smoking • Low body weight (under 127 #)

  7. Other Screening Considerations • Hyperthyroidism • Hyperparthyroidism • X-ray evidence of low bone mass • Vitamin D deficiency (osteo-malacia) • Rheumatoid arthritis • Medications known to cause bone loss • Diseases that cause poor intestinal absorption • Long term menstrual irregularities

  8. Tools for Diagnosing and Monitoring Response to Treatment • Thorough H&PE • Lab • X-rays • Bone densiometry • US • Bone markers

  9. History and Physical Assessment • Assess risk factors • Identify a history of falls/fractures • Weight, height, general health • Spine/bony structure assessment • Gait and balance

  10. Laboratory and X-Ray Studies • Lab: • CBC, serum calcium, phosphorus, alkaline phosphatase, renal function, TSH. • Possible additional lab: 24 hours urine for creatinine and calcium, parathyroid hormone assay, LFTs, serum testosterone, cortisol assays, protein electrophoresis • X-Ray: • Useful when fractures are suspected, not effective for screening

  11. Dual Energy X-ray Absorptiometry (DEXA) • The gold standard for diagnosis and monitoring • Non-invasive • Low x-ray exposure • High sensitivity and specificity • Limitations: • Osteoarthritis, aortic calcification, or compression fracture may yield erroneous values in the spine. Use proximal femur measurements.

  12. DEXA Interpretation Diagnostic Criteria for Osteoporosis in Post-menopausal Women CategoryDefinition by BMD Score NormalBMD <1 SD below mean value for young adult white females OsteopeniaBMD 1-2.5 SD below mean value for young adult white females OsteoporosisBMD > 2.5 SD below the mean value for young adult white females

  13. Other Tools for Osteoporosis Evaluation • Quantitative ultrasound • Heel, finger, tibia, patellar measurements • Inexpensive • No radiation • Less sensitive than DEXA • Bone markers • Measure osteoblastic or osteoclastic activity • Research instrument

  14. Monitoring and Evaluating Treatment of Osteopenia/Osteoporosis • Follow-up DEXAs only when change might result • Follow-up DEXA for patients with normal or minimally low BMD every 3-5 years • Patients on medication-repeat DEXA 18 to 24 months after therapy was begun

  15. Summary of Part 2: Diagnosis and Monitoring • There are various screening methods • paper and pencil testing • History and physical risk assessment • Formal laboratory/x-ray studies • DEXA is the gold standard for diagnosis and monitoring of both osteopenia and osteoporosis

  16. The End of Module Two on Osteoporosis References • Bone Health and Osteoporosis: A Report of the Surgeon General, USDHHS, issued October 14, 2004 www.surgeongeneral.gov/library/bonehealth • Cadarette et al, Development and validation of the osteoporosis risk assessment instrument to facilitate selection of women for bone densiometry. CMAJ, 2000, May 2,162(9):1289-94 • Cadarette et al, The validity of decision rules for selecting women with primary osteoporosis for BMD testing. Osteoporosis Int, 2004, Jan 17 • Lydick et al, Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care, 1998, Jan 4(1):37-48 • National Osteoporosis Foundation. America’s bone health: The state of osteoporosis and low bone mass in our nation. Washington (DC): National Osteoporosis Foundation; 2002 • US Preventive Services Task Force. Screening for osteoporosis in postmenopausal; women: Recommendations and rationale. Ann Intern Med, 2002, Sept 17; 137(6):526-8

  17. Post-test A 65 year old woman returns to your office after DEXA testing to discuss her results. Noting that her total BMD is -2.2, you inform her she has: • Normal bone mass • Osteopenia • Osteoporosis • Severe osteoporosis

  18. Correct Answer: Osteopenia Feedback: Osteopenia.Bone mass is considered to be in the normal range if < -1.0. Results falling between -1.0 and -2.5 diagnose osteopenia, and results > -2.5 make the diagnosis for osteoporosis. A patient in the osteoporotic range who has also had a fracture can be said to have severe osteoporosis. End

More Related